Astaamaha, Daaweynta, iyo Saadaalinta
Marxaladda 4 kaansarka sanbabada unugyada yaryar (kansarka sanbabada ee sanbabada) ayaa ah heerka ugu sareeya ee kansarka sanbabada . Ku dhowaad 40 boqolkiiba dadka cusub ee laga helay cudurka kansarka sanbabada mar hore waxay leeyihiin marxalad 4. Marxaladan oo ah kansarka sanbabadu maaha mid la daaweyn karo, laakiin waa la daweyn karaa , tijaabooyin badan oo daaweyn ahna waa la socdaa oo eegaya daaweyn cusub si loo hagaajiyo badbaadada.
Guudmarka
Marxaladda 4 kaansarka unugyada yar-yar ee unugyada yar-yar ayaa qeexaya qanjirada sambabka ee cabbir kasta oo ku faafay qaybo jidhka ah, lafo kale oo sambabada ah, ama ay la socoto finan-jeexjeexeedka ilmagaleenka .
Astaamaha
Kuwaas waxaa ka mid ah:
Astaamaha waxaa sabab u ah jiritaanka buro sanbabada sida:
- Qufac aan joogto ahayn
- Qufacista dhiigga (hemoptysis)
- Neefsasho gaabis ah
- Hooska
- Xaji laabta, dhabarka , garabka ama gacmaha
- Qaybaha soo noqnoqda ee oof-wareenka ama boronkiitada
- Xiiqda
Astaamaha waxaa sabab u ah fidista burooyinka ee gobollada kale ee jirka , tusaale ahaan:
- Xanuunka dhabarka, miskaha, ama feeraha haddii buro ay ku faafto lafaha
- Dhibaato liqitaan awgeed sababtoo ah buro ayaa ku dhow ama soo galaya hunguriga
- Madax xanuun, isbedel aragti, tabar-dari, ama suuxdin haddii buro ku faafto maskaxda
- Jaundice (maqaarka maqaarka) oo ka imanaya buro ku faaftay beerka
Iyo calaamadaha la xidhiidha kansarka heerkulka guud :
Daaweynta
Sababtoo ah marxaladda 4-aad ee kansarka sanbabadu waxay ka fiddaa sambabada, waxaa loo tixgeliyaa in aan la isticmaali karin , taas oo ah, qalliinku ma awoodi karo in uu ka saaro dhammaan burooyinka iyo inuu siiyo fursad daawo.
Laakiin marxaladda 4 kaansarka sanbabada waa la daweyn karaa. Kuwa u adkeysan kara daaweynta kiimiko, daaweynta kiimikada caadiga ah, difaaca jirka , iyo / ama daaweynta cusub ee la beegsado waxay kor u qaadi kartaa badbaadada iyo caawinta calaamadaha kansarka sanbabada. Daraasaadyo badan oo caafimaad ayaa socda oo eegaya daaweyn cusub oo lagu beegsanayo, isku-darka daaweynta kiimiko iyo daaweynta la beegsado iyo sidoo kale talaal difaaceed.
Daaweynta shucaaca waxaa lagula talin karaa daaweynta palliative - daaweyn la sameeyo si loo xakameeyo calaamadaha laakiin aaney keenin daawo. Tani waxay caawinaysaa dadka qaarkood si loo xakameeyo xanuunka lafaha (sababtoo ah burooyinka ku faafaya lafaha), dhiig baxa sanbabada, burooyinka ka hor istaagaya marinnada hawada iyo keena neefta gaaban, ama maskaxaha maskaxda ee keena calaamado muuqda, sida madax xanuun ama daciifnimo.
Hadda waxa lagula talinayaa in dhammaan bukaanada qaba adenocarcinoma sambabada sare iyo qaar dadka qaba xanuunka unugyada ee sanbabada ee sambabada waa inay leeyihiin baaritaan hiddesid (sheyga molecular) ee lagu sameeyo burooyinkooda. Qayb ka mid ah dadka ku dhacda isbeddellada EGFR , dib-u-habaynta ALK , ama daawooyinka dib-u-habaynta ee ROS1 ayaa la heli karaa kaas oo kordhin kara sii-noolaanshaha aan wali lahayn.
Immunotherapy waa nooc kale oo cusub oo daaweynta kansarka sanbabada, iyada oo daawada ugu horeysa ee kooxdani loo oggolaaday kansarka sanbabada sanadka 2015. Iyadoo daawooyinkaas aysan u shaqaynin qof walba, dadka qaba kansarka sambabada sare waxay la kulmeen muddo dheer cudurka qaba daroogooyinkaas.
Waa muhiim inaad kala hadashid daaweyn kasta oo aad ka fekereyso dhakhtarkaaga iyo kuwa aad jeceshahay, si aad si taxadar leh u miisaamiso khatarta iyo faa'iidooyinka daaweynta.
Saadaasha
Heerka 4-sano ee badbaadada noolaha ee heerka 4-aad ee kansarka sanbabada ayaa aad u xun oo ku dhawaad boqolkiiba 1. Waqtiga badbaadada dhexdhexaadka ah (wakhtiga boqolkiiba 50 ee bukaanadu nool yihiin iyo 50 boqolkiiba ay dhinteen) waxay qiyaastii 8 bilood.
Maxaan sameyn karaa si aan nafteyda u caawiyo?
Cilmi-baaristu waxay soo jeedinaysaa in aad baran karto waxa aad ka qaban karto kansarka sanbabadaada waxay hagaajin kartaa tayada noloshaada, iyo weliba xitaa xitaa natiijadaada. Weydii su'aalo. Baro tijaabooyinka bukaan socodka. Ka fikir inaad ku biirto koox taageero ah . Qaar badan oo naga mid ah ayaa ka walaacsan in ay ka hadlaan arimaha dhammaadka nolosha , laakiin kala hadal arintan dhakhtarkaaga iyo qoyskaaga - xitaa haddii dhamaantiin rajaynayo daaweyn - waxay la xiriirtaa dareenka yaraanta ee kali ah iyo tayada nololeed ee tayada leh.
Weligaa waayi rajo, xitaa haddii aad dooratay inaadan sii wadin daaweyn dheeraad ah. Rajada waqtiga tayada leh kuwa aad jeceshahay , adigoo xakameynaya astaamahaaga. Rajada mustaqbalka dadka aad jeceshahay ee ku sii jiri doona, adiga oo xusuusinaya in aad qalbiyadooda.
> Ilo:
> Bulshada Mareykanka ee Kansarka. Xaqiiqooyinka Kansarka iyo Sawirrada 2014 . Atlanta: Bulshada Mareykanka ee Kansarka; 2014. http://www.cancer.org/acs/groups/content/@research/documents/webcontent/acspc-042151.pdf.
> Bulshada Mareykanka ee Kansarka. Kansarka Sambabka (Unugyada Hoose-yar). Qiyaasaha Kansarka Cudurka Kansarka Cudurka aan-yareyn ee Qaybaha Heerka. http://www.cancer.org/cancer/lungcancer-non-smallcell/detailedguide/non-small-cell-lung-cancer-survival-rates.
> Guddiga Wadajirka ee Maraykanka ee Kansarka. Kansarka Lung Cancer. Warka 7aad. https://cancerstaging.org/references-tools/quickreferences/Documents/LungMedium.pdf .
> Edge, S. et al (Eds.). Buugga Dheecaanka Kansarka AJCC. Warka 7aad. Duufaan. New York, NY. 2010.
> Faithi, A. iyo J. Brahmer. Daweynta Chemotherapy ee Heerka Horukaca ee Kansarka Kansarka sanbabada aan yareyn. Seminarrada Qalliinka Thoracic iyo Qalitaanka wadnaha . 2008. 20 (3): 210-6.
> Machadka Kansarka Qaranka. Kansarka Kansarka sanbabada aan yareyn (PDQ). Heerka IV Kansarka Sambabka Unugyada yar-yar. https://www.cancer.gov/cancertopics/pdq/treatment/non-small-cell-lung/HealthProfessional/page12.
> Machadka Kansarka Qaranka. Daaweynta Cudurka Kansarka sanbabada aan yareyn (PDQ) - Qaybta Caafimaadka Shaqaalaha ah http://www.cancer.gov/types/lung/hp/non-small-cell-lung-treatment-pdq#section/all.